Literature DB >> 17681841

An alternative splice form of CMTM8 induces apoptosis.

Dan Li1, Caining Jin, Caihua Yin, Yingmei Zhang, Bo Pang, Linjie Tian, Wenling Han, Dalong Ma, Ying Wang.   

Abstract

Previous studies have demonstrated that the chemokine-like factor (CKLF)-like MARVEL transmembrane domain containing 8 (CMTM8) protein accelerates the ligand-induced clearance of epidermal growth factor receptor (EGFR) from the cell surface. The absence of EGFR-mediated signaling induces cells to undergo apoptosis via caspase-dependent and -independent pathways. Here we report the cloning and sequencing of an alternative splice form of CMTM8, obtained from a human blood cDNA library, that utilizes apoptotic pathways distinct from CMTM8. The alternative splice variant arises from a deletion of exon 2 that prevents the expression of a full-length MARVEL domain, and cytosolic YXXPhi motifs. Nevertheless, CMTM8-v2 maintains the ability to induce apoptosis via caspase-dependent and -independent pathways to inhibit cell growth and colony formation. CMTM8 and CMTM8-v2 display different expression profiles and distinct subcellular localization patterns, while operating via different mechanisms to induce apoptosis. CMTM8-v2 did not affect EGFR internalization, implying that the MARVEL domain and/or the cytosolic YXXPhi motifs are necessary for CMTM8 to accelerate ligand-induced EGFR internalization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681841     DOI: 10.1016/j.biocel.2007.06.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Authors:  J Xie; Y Yuan; Z Liu; Y Xiao; X Zhang; C Qin; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

3.  Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.

Authors:  Wenjuan Zhang; Michelle C Mendoza; Xiaolei Pei; Didem Ilter; Sarah J Mahoney; Yingmei Zhang; Dalong Ma; John Blenis; Ying Wang
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

4.  Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.

Authors:  Shiying Zhang; Xiaolei Pei; Hao Hu; Wenjuan Zhang; Xiaoning Mo; Quansheng Song; Yingmei Zhang; Kexin Xu; Ying Wang; Yanqun Na
Journal:  Tumour Biol       Date:  2015-11-28

5.  Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.

Authors:  Joeri Both; Oscar Krijgsman; Johannes Bras; Gerard R Schaap; Frank Baas; Bauke Ylstra; Theo J M Hulsebos
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

6.  Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.

Authors:  Tianci Han; Tianci Shu; Siyuan Dong; Peiwen Li; Weinan Li; Dali Liu; Ruiqun Qi; Shuguang Zhang; Lin Zhang
Journal:  Oncol Lett       Date:  2017-03-10       Impact factor: 2.967

Review 7.  CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.

Authors:  Jie Wu; Lan Li; Siyi Wu; Bin Xu
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 8.  Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.

Authors:  Mengxia Li; Fangzhou Luo; Xinyao Tian; Shengyong Yin; Lin Zhou; Shusen Zheng
Journal:  Front Oncol       Date:  2020-11-13       Impact factor: 6.244

9.  CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Zesong Li; Jun Xie; Jianting Wu; Wenjie Li; Liping Nie; Xiaojuan Sun; Aifa Tang; Xianxin Li; Ren Liu; Hongbing Mei; Feng Wang; Zhiping Wang; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

Authors:  Denghui Gao; Hao Hu; Ying Wang; Weidong Yu; Jianhua Zhou; Xiaofeng Wang; Weiping Wang; Chunyan Zhou; Kexin Xu
Journal:  Oncol Rep       Date:  2015-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.